Saturday - February 7, 2026
SEC Charges Kentucky-Based Biopharmaceutical Company and Two Executives With Defrauding Investors
February 07, 2026
WASHINGTON, Feb. 7 -- The Securities and Exchange Commission issued the following litigation release (No. 26-cv-00042; E.D. Ky. filed Feb. 5, 2026):

* * *

Securities and Exchange Commission v. CBA Pharma, Inc., et al., No. 26-cv-00042 (E.D. Ky. filed Feb. 5, 2026)

On February 5, 2026, the Securities and Exchange Commission filed charges against CBA Pharma, Inc., a private Kentucky-based biopharmaceutical company; Wayne Michael Putnam, its president; and Lou . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products